Sangeeta N. Bhatia - Net Worth and Insider Trading
Sangeeta N. Bhatia Net Worth
The estimated net worth of Sangeeta N. Bhatia is at least $2 Million dollars as of 2024-11-10. Sangeeta N. Bhatia is the Director of Vertex Pharmaceuticals Inc and owns about 4,435 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $2 Million. Details can be seen in Sangeeta N. Bhatia's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sangeeta N. Bhatia has not made any transactions after 2024-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sangeeta N. Bhatia
Sangeeta N. Bhatia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sangeeta N. Bhatia owns 1 companies in total, including Vertex Pharmaceuticals Inc (VRTX) .
Click here to see the complete history of Sangeeta N. Bhatia’s form 4 insider trades.
Insider Ownership Summary of Sangeeta N. Bhatia
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2024-08-30 | director |
Sangeeta N. Bhatia Latest Holdings Summary
Sangeeta N. Bhatia currently owns a total of 1 stock. Sangeeta N. Bhatia owns 4,435 shares of Vertex Pharmaceuticals Inc (VRTX) as of August 30, 2024, with a value of $2 Million.
Latest Holdings of Sangeeta N. Bhatia
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2024-08-30 | 4,435 | 516.74 | 2,291,742 |
Holding Weightings of Sangeeta N. Bhatia
Sangeeta N. Bhatia Form 4 Trading Tracker
According to the SEC Form 4 filings, Sangeeta N. Bhatia has made a total of 14 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 646 shares on August 30, 2024, which brought Sangeeta N. Bhatia around $323,000.
Insider Trading History of Sangeeta N. Bhatia
- 1
Sangeeta N. Bhatia Trading Performance
Sangeeta N. Bhatia Ownership Network
Ownership Network List of Sangeeta N. Bhatia
Ownership Network Relation of Sangeeta N. Bhatia
Sangeeta N. Bhatia Owned Company Details
What does Vertex Pharmaceuticals Inc do?
Who are the key executives at Vertex Pharmaceuticals Inc?
Sangeeta N. Bhatia is the director of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP and Chief Legal Officer Jonathan Biller , EVP and CMO Carmen Bozic , and director & CEO & President Reshma Kewalramani .
Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary
Over the past 18 months, Sangeeta N. Bhatia made 6 insider transaction in Vertex Pharmaceuticals Inc (VRTX) with a net sale of 3,132. Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 47,585 shares made by Carmen Bozic , a net sale of 16,533 shares made by Ourania Tatsis , and a net sale of 77,232 shares made by Reshma Kewalramani .
In summary, during the past 3 months, insiders sold 5,429 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 5,429 shares. During the past 18 months, 340,041 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 340,041 shares.
Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vertex Pharmaceuticals Inc Insider Transactions
Sangeeta N. Bhatia Mailing Address
Above is the net worth, insider trading, and ownership report for Sangeeta N. Bhatia. You might contact Sangeeta N. Bhatia via mailing address: C/o Vertex Pharmaceuticals, Inc., 50 Northern Avenue, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
